ABAT and myeloid sarcoma: Furthermore, enhancing endogenous GABA via administration of the GABA-degrading enzyme GABA-transaminase (GABA-T), has been shown to be protective in an experimental autoimmune encephalomyelitis (EAE) mouse model (Carmans et al., 2013), indicating that increasing endogenous GABA also has therapeutic potential in the murine model of MS.